Dysphagia in Oculopharyngeal Muscular Dystrophy (OPMD)- Evaluation, Endoscopic Examination of Swallowing, Treatment and Long Term Follow up

Sponsor
Hillel Yaffe Medical Center (Other)
Overall Status
Unknown status
CT.gov ID
NCT01167439
Collaborator
(none)
40
1
2

Study Details

Study Description

Brief Summary

The investigators aimed to review the natural history of dysphagia and dysphonia in OPMD in order to identify the best candidates and the proper timing to perform dysphagia alleviating procedures in both heterozygote and homozygote patients from the large pool of cases with this disease in Israel.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Upper esophageal sphincter myotomy
Phase 1

Detailed Description

Clinical evaluation of patients suspected of having OPMD. Genetic confirmatory tests (diagnostic DNA test) at the genetic unit in Afula Hospital. Clinical follow-up with endoscopic fiber optic evaluation of swallowing. Pre-operative assessment. Crycopharyngeal myotomy intervention in selected patients. Nutrition follow-up.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Non-Randomized
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Dysphagia in Oculopharyngeal Muscular Dystrophy. Evaluation, Endoscopic Examination of Swallowing, Treatment and Long Term Follow up.
Study Start Date :
Jul 1, 2009
Anticipated Primary Completion Date :
Jul 1, 2011

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Mild dysphagia

Active Comparator: Severe dysphagia

Procedure: Upper esophageal sphincter myotomy
Upper esophageal sphincter release operation to allow better swallowing. The intervention is done under GA and by extra-mucosal approach.

Outcome Measures

Primary Outcome Measures

  1. Dysphagia, quality of life. Proper intervention timing in OPMD based on knowledge about the natural history of the feeding difficulty. [at least 3 years]

    Dysphagia, quality of life. Proper intervention timing in OPMD patients is very important and must be based on deep knowledge about the natural history of the feeding difficulty.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • heterozygote and homozygote OPMD patients
Exclusion Criteria:

Contacts and Locations

Locations

Site City State Country Postal Code
1 Israel National Center for OPMD and Dysphagia, HYMC POB 169, Hadera Israel 38100

Sponsors and Collaborators

  • Hillel Yaffe Medical Center

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT01167439
Other Study ID Numbers:
  • 0027-09-HYMC
First Posted:
Jul 22, 2010
Last Update Posted:
Jul 22, 2010
Last Verified:
Dec 1, 2009

Study Results

No Results Posted as of Jul 22, 2010